|KARBF -- USA Stock|| |
USD 4.00 0.45 12.68%
Mr. Per Anders Johansson has served as Independent Member of the Board of Directors at Karo Bio AB since June 12 2012. He is also Chief Executive Officer and Chairman of CIMON and Chairman of the Savings bank in Karlshamn. He is Founder of the technical consulting company CIMON AB as well as Chief Financial Officer and Vice President of Ellos Nordico and the Karlshamn Group.
Age: 60 Executive Since 2012
46 1 03 30 23 10 http://www.karopharma.se
The company has return on total asset (ROA)
of 1.81 %
which means that it generated profit of $1.81 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 1.26 %
meaning that it generated $1.26 on every $100 dollars invested by stockholders.
The company has accumulated 293.75 M in total debt with debt to equity ratio (D/E) of 155.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Karo Pharma AB has Current Ratio of 1.09 suggesting that it may not be capable to disburse its financial obligations in time and when they become due.
Karo Pharma AB , a healthcare company, develops and markets products for elderly people in Sweden, Norway, Denmark, and Finland. Karo Pharma AB was founded in 1987 and is based in Stockholm, Sweden. Karo Pharma is traded on OTC Market in USA.Karo Pharma AB (KARBF) is traded on OTC Market in USA. It is located in Nybrokajen 7 and employs 39 people.
Karo Pharma AB Leadership Team
|PerAnders Johansson, Independent Director|
|Jean Lycke, Director|
|Per Johansson, Member of the Board|
|Peter Blom, CEO|
|Henrik Palm, CFO|
|Anders Lonner, Chairman of the Board|
|Marianne Hamilton, Director|
|Maria Sjoberg, Vice President Chief Scientific Officer, responsible for Preclinical Research and Development|
|Hakan Astrom, Director|
|Thomas Kraft, Country Manager Norway|
|Goran Wessman, Director|
|Bo Carlsson, Member of the Board, Employee Representative|
|Thomas Hedner, Director|
Stock Performance Indicators
Macroaxis portfolio users are evenly split in their trading attitude regarding investing in Karo Pharma AB. What is your trading attitude regarding investing in Karo Pharma AB? Are you bullish or bearish?
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations